all report title image

ARTIFICIAL INTELLIGENCE (AI) IN BIOTECHNOLOGY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Artificial Intelligence (AI) in Biotechnology Market, By Component (Software, Hardware, Services), By Application (Drug Discovery & Development, Clinical Trials & Optimization, Medical Imaging, Diagnostics, Others), By End User (Pharmaceutical Companies, Biotechnology Companies, Academic & Research Institutes, Healthcare Providers, CRO & CDMO, Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

  • Published In : Jul 2024
  • Code : CMI7132
  • Pages :171
  • Formats :
      Excel and PDF
  • Industry : Healthcare IT
Ingographics Image

The field of biotechnology has witnessed rapid advancements due to technological developments in various domains including artificial intelligence and machine learning. AI is being increasingly used in biotechnology for applications ranging from drug discovery and genome analysis to clinical trial monitoring and precision medicine. AI tools help researchers to process huge volumes of genomic and proteomic data and gain novel insights into disease mechanisms. Several AI-powered techniques like deep learning, neural networks, natural language processing, and others assist in critical functions like target identification, lead optimization, toxicity prediction and biomarker discovery, thus, significantly accelerating the drug development process. AI help biotech companies in monitoring and managing clinical trials more efficiently. It also has promising applications in personalized medicine by supporting treatment recommendations tailored to individual patients' genetic profile and medical history. Global AI in biotechnology market growth is driven by rising adoption of these technologies in pharma/biotech industry and healthcare.

Market Dynamic:

Global AI in biotechnology market growth is driven by factors like increasing funding for AI startups developing solutions for healthcare and life sciences, growing volumes of complex biological and patient-generated healthcare data requiring sophisticated analysis, and rising need to enhance R&D productivity and reduce costs in drug discovery. However, factors like lack of skilled workforce, data quality issues, security and regulatory concerns related to AI and big data can hamper its adoption. Expanding applications of predictive analytics, machine learning and artificial intelligence in precision medicine, personalized therapeutics, gene therapies and diagnostics can offer market growth opportunities.

Key Features of the Study:

  • This report provides in-depth analysis of the global AI in biotechnology market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global AI in biotechnology market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Intel Corporation, NVIDIA Corporation, IBM Corporation, Microsoft Corporation, Amazon Web Services, Anthropic, Berg Health, Deep Genomics, Enlitic, twoXAR, and Insilico Medicine
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global AI in biotechnology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Detailed Segmentation-

  • By Component
    • Software
    • Hardware
    • Services
  • By Application
    • Drug Discovery & Development 
    • Clinical Trials & Optimization
    • Medical Imaging
    • Diagnostics
    • Others
  • By End User
    • Pharmaceutical Companies
    • Biotechnology Companies 
    • Academic & Research Institutes 
    • Healthcare Providers
    • CRO & CDMO
    • Others
  • By Region:         
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • AstraZeneca
    • Bristol-Myers Squibb
    • Gilead Sciences, Inc.
    • Sanofi
    • Abbott Laboratories
    • Biogen
    • Pfizer, Inc.
    • Novo Nordisk A/S
    • Amgen, Inc.
    • Merck KGaA
    • Johnson & Johnson Services, Inc.
    • Hoffmann-La Roche Ltd.
    • Novartis AG
    • Deep Genomics
    • NVIDIA Corporation
    • Verge Genomics
    • Recursion Pharmaceuticals

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Component
      • Market Snapshot, By Application
      • Market Snapshot, By End User
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Regulatory Scenario
    • Acquisitions and Partnerships Scenario
    • Funding and Investments
    • PEST Analysis
    • Porter’s Analysis
  4. Global AI in Biotechnology Market - Impact of Coronavirus (COVID-19) Pandemic
    • Overall Impact
    • Government Initiatives
    • COVID-19 Impact on the Market
  5. Global AI in Biotechnology Market, By Component, 2019 – 2031, (USD Bn)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2020 – 2031
      • Segment Trends
    • Software
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Hardware
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Services
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
  6. Global AI in Biotechnology Market, By Application, 2019 – 2031, (USD Bn)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2020 – 2031
      • Segment Trends
    • Drug Discovery & Development
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Clinical Trials & Optimization
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Medical Imaging
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Diagnostics
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
  7. Global AI in Biotechnology Market, By End User, 2019 – 2031, (USD Bn)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2020 – 2031
      • Segment Trends
    • Pharmaceutical Companies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Biotechnology Companies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Academic & Research Institutes
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Healthcare Providers
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • CRO & CDMO
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
  8. Global AI in Biotechnology Market, By Region, 2019 – 2031, (USD Bn)
    • Introduction
      • Market Share Analysis, By Region, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, For Region, 2020–2031
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD Bn)
        • North Africa
        • Central Africa
        • South Africa
  9. Competitive Landscape
    • Company Profiles
      • AstraZeneca
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Bristol-Myers Squibb
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Gilead Sciences, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Sanofi
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Abbott Laboratories
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Biogen
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Pfizer, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Novo Nordisk A/S
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Amgen, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Merck KGaA
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Johnson & Johnson Services, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • F. Hoffmann-La Roche Ltd.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Novartis AG
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Deep Genomics
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • NVIDIA Corporation
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Verge Genomics
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Recursion Pharmaceuticals
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
  10. Analyst Recommendations
    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  11. References and Research Methodology
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 32 market data tables and 28 figures on "AI in Biotechnology Market” - Global forecast to 2031

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2025 Coherent Market Insights Pvt Ltd. All Rights Reserved.